Other languages The Oncology Institute, Inc.

Equities

TOI

US68236X1000

End-of-day quote Nasdaq Other stock markets 03:30:00 03/05/2024 am IST			5-day change	1st Jan Change
1.07 ^USD	-7.76%		-1.83%	-47.55%

08/04	The Oncology Institute, Inc. Appoints Jordan McInerney as New Chief Development Officer	CI
04/04	The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

The Oncology Institute, Inc. Appoints Jordan McInerney as New Chief Development Officer	08/04
The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California	04/04
The Oncology Institute Q4 Loss Widens, Revenue Increases	28/03
The Oncology Institute, Inc. Provides Earnings Guidance for the Year 2024	28/03
The Oncology Institute, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	27/03
MaxHealth & The Oncology Institute, Inc. Expand Value-Based Care Partnership	14/03
The Oncology Institute Expands Its Specialty Medication Business by Opening Pharmacy Operations in California	04/12
Oncology Institute Insider Sold Shares Worth $118,581, According to a Recent SEC Filing	16/11
The Oncology Institute, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
The Oncology Institute, Inc. Reaffirms Earnings Guidance for the Year 2023	09/11
The Oncology Institute, Inc. Names Jeremy Castle as Chief Operations Officer	12/23/12
The Oncology Institute Regains Compliance With Nasdaq's Minimum Closing Bid Price Rule	18/23/18
The Oncology Institute, Inc. Appoints Jeremy N. Castle as Chief Operations Officer	07/23/07
The Oncology Institute, Inc. Announces Resignation of Ravi Sarin as Member of the Board of Directors and Committees	02/23/02
The Oncology Institute, Inc. announces an Equity Buyback for 2,000,000 shares, for $2 million.	31/23/31
The Oncology Institute, Inc. authorizes a Buyback Plan.	28/23/28
Oncology Institute Signs Agreement With Ambience Healthcare to Adopt AI Operating System for Oncology Care	09/23/09
The Oncology Institute, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	09/23/09
The Oncology Institute, Inc. Reaffirms Earnings Guidance for the Full Year 2023	09/23/09
The Oncology Institute Partners with House Rx to Accelerate Growth of Pharmacy Operations	31/23/31

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages The Oncology Institute, Inc.

Equities

TOI

US68236X1000

Other languages

Filters